These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23555776)

  • 1. The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.
    Kong LQ; Zhu XD; Xu HX; Zhang JB; Lu L; Wang WQ; Zhang QB; Wu WZ; Wang L; Fan J; Tang ZY; Sun HC
    PLoS One; 2013; 8(3):e59771. PubMed ID: 23555776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma.
    Sugaya M; Miyagaki T; Ohmatsu H; Suga H; Kai H; Kamata M; Fujita H; Asano Y; Tada Y; Kadono T; Okochi H; Sato S
    J Dermatol Sci; 2012 Oct; 68(1):45-51. PubMed ID: 22884782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients.
    Medrek C; Pontén F; Jirström K; Leandersson K
    BMC Cancer; 2012 Jul; 12():306. PubMed ID: 22824040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of M2-polarized macrophages is associated with poor prognosis for advanced epithelial ovarian cancer.
    Lan C; Huang X; Lin S; Huang H; Cai Q; Wan T; Lu J; Liu J
    Technol Cancer Res Treat; 2013 Jun; 12(3):259-67. PubMed ID: 23289476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
    Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
    BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of the infiltration of CD163
    Huang X; Pan Y; Ma J; Kang Z; Xu X; Zhu Y; Chen J; Zhang W; Chang W; Zhu J
    Cancer Med; 2018 May; 7(5):1731-1741. PubMed ID: 29573574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated CD163
    Yang C; Wei C; Wang S; Shi D; Zhang C; Lin X; Dou R; Xiong B
    Int J Biol Sci; 2019; 15(5):984-998. PubMed ID: 31182919
    [No Abstract]   [Full Text] [Related]  

  • 8. CD68, CD163, and matrix metalloproteinase 9 (MMP-9) co-localization in breast tumor microenvironment predicts survival differently in ER-positive and -negative cancers.
    Pelekanou V; Villarroel-Espindola F; Schalper KA; Pusztai L; Rimm DL
    Breast Cancer Res; 2018 Dec; 20(1):154. PubMed ID: 30558648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral and peritumoral expression of CD68 and CD206 in hepatocellular carcinoma and their prognostic value.
    Ren CX; Leng RX; Fan YG; Pan HF; Li BZ; Wu CH; Wu Q; Wang NN; Xiong QR; Geng XP; Ye DQ
    Oncol Rep; 2017 Aug; 38(2):886-898. PubMed ID: 28656201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic significance of CD68
    Troiano G; Caponio VCA; Adipietro I; Tepedino M; Santoro R; Laino L; Lo Russo L; Cirillo N; Lo Muzio L
    Oral Oncol; 2019 Jun; 93():66-75. PubMed ID: 31109698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD163 immunohistochemistry is superior to CD68 in predicting outcome in classical Hodgkin lymphoma.
    Klein JL; Nguyen TT; Bien-Willner GA; Chen L; Foyil KV; Bartlett NL; Duncavage EJ; Hassan A; Frater JL; Kreisel F
    Am J Clin Pathol; 2014 Mar; 141(3):381-7. PubMed ID: 24515766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune Cell-Associated Protein Expression Helps to Predict Survival in Muscle-Invasive Urothelial Bladder Cancer Patients after Radical Cystectomy and Optional Adjuvant Chemotherapy.
    Taubert H; Eckstein M; Epple E; Jung R; Weigelt K; Lieb V; Sikic D; Stöhr R; Geppert C; Weyerer V; Bertz S; Kehlen A; Hartmann A; Wullich B; Wach S
    Cells; 2021 Jan; 10(1):. PubMed ID: 33467469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of CD163 expression and its correlation with cyclooxygenase-2 and vascular endothelial growth factor expression in cutaneous melanoma.
    Lee WJ; Lee MH; Kim HT; Won CH; Lee MW; Choi JH; Chang SE
    Melanoma Res; 2019 Oct; 29(5):501-509. PubMed ID: 30575644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage colony-stimulating factor expressed in non-cancer tissues provides predictive powers for recurrence in hepatocellular carcinoma.
    Kono H; Fujii H; Furuya S; Hara M; Hirayama K; Akazawa Y; Nakata Y; Tsuchiya M; Hosomura N; Sun C
    World J Gastroenterol; 2016 Oct; 22(39):8779-8789. PubMed ID: 27818593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential association of CD68
    Tremble LF; McCabe M; Walker SP; McCarthy S; Tynan RF; Beecher S; Werner R; Clover AJP; Power XDG; Forde PF; Heffron CCBB
    Br J Cancer; 2020 Nov; 123(10):1553-1561. PubMed ID: 32843682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher density of stromal M2 macrophages in breast ductal carcinoma in situ predicts recurrence.
    Chen XY; Thike AA; Md Nasir ND; Koh VCY; Bay BH; Tan PH
    Virchows Arch; 2020 Jun; 476(6):825-833. PubMed ID: 31897820
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High intratumoral macrophage content is an adverse prognostic feature in anaplastic large cell lymphoma.
    Pedersen MB; Danielsen AV; Hamilton-Dutoit SJ; Bendix K; Nørgaard P; Møller MB; Steiniche T; d'Amore F
    Histopathology; 2014 Oct; 65(4):490-500. PubMed ID: 24592992
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD86⁺/CD206⁺, Diametrically Polarized Tumor-Associated Macrophages, Predict Hepatocellular Carcinoma Patient Prognosis.
    Dong P; Ma L; Liu L; Zhao G; Zhang S; Dong L; Xue R; Chen S
    Int J Mol Sci; 2016 Mar; 17(3):320. PubMed ID: 26938527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage Activation Marker Soluble CD163 Is a Dynamic Marker of Liver Fibrogenesis in Human Immunodeficiency Virus/Hepatitis C Virus Coinfection.
    Lidofsky A; Holmes JA; Feeney ER; Kruger AJ; Salloum S; Zheng H; Seguin IS; Altinbas A; Masia R; Corey KE; Gustafson JL; Schaefer EA; Hunt PW; Deeks S; Somsouk M; Chew KW; Chung RT; Alatrakchi N
    J Infect Dis; 2018 Sep; 218(9):1394-1403. PubMed ID: 29868909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The number and localization of CD68+ and CD163+ macrophages in different stages of cutaneous melanoma.
    Salmi S; Siiskonen H; Sironen R; Tyynelä-Korhonen K; Hirschovits-Gerz B; Valkonen M; Auvinen P; Pasonen-Seppänen S
    Melanoma Res; 2019 Jun; 29(3):237-247. PubMed ID: 30399061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.